Status:
TERMINATED
A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Non-Squamous Non-Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This single arm genetic substudy of MO19390 will test the hypothesis that there is a positive relationship between mRNA BRCAI levels and the response to different chemotherapy combinations plus Avasti...
Eligibility Criteria
Inclusion
- participating in, and meeting all inclusion/exclusion criteria of, MO19390.
Exclusion
- not meeting the inclusion/exclusion criteria of MO19390.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT00642824
Start Date
May 1 2007
End Date
December 1 2009
Last Update
November 2 2016
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcorcón, Spain, 28922
2
Alcoy, Spain, 03804
3
Alicante, Spain, 03010
4
Badalona, Spain, 08915